ScholarIQanswers from OpenAlex

Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis

PaperCitations, authors & open-access status

Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis have?

ScholarIQcitation count

Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis has 39 citations in the OpenAlex counts ScholarIQ stores.

When was Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis published?

ScholarIQyear

Open the OpenAlex record →

What is the open-access status of Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?

ScholarIQoa status

Open the OpenAlex record →

What is the DOI of Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?

ScholarIQdoi

The DOI for Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis is on the source record.

Open the DOI →

What is the PMID of Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?

ScholarIQpmid

The PMID for Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis is on the source record.

Open the PMID →

What is the OpenAlex record for Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?

ScholarIQopenalex

The OpenAlex for Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis is on the source record.

Open the OpenAlex →

Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis

How many citations does Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis have?

When was Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis published?

What is the open-access status of Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?

What is the DOI of Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?

What is the PMID of Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?

What is the OpenAlex record for Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?

Related on ScholarIQ